Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 11;11(25):6393-6404.
doi: 10.1039/d0sc01140a.

Chemical synthesis of human syndecan-4 glycopeptide bearing O-, N-sulfation and multiple aspartic acids for probing impacts of the glycan chain and the core peptide on biological functions

Affiliations

Chemical synthesis of human syndecan-4 glycopeptide bearing O-, N-sulfation and multiple aspartic acids for probing impacts of the glycan chain and the core peptide on biological functions

Weizhun Yang et al. Chem Sci. .

Abstract

Proteoglycans are a family of complex glycoproteins with glycosaminoglycan chains such as heparan sulfate (HS) attached to the core protein backbone. Due to the high structural heterogeneity of HS in nature, it is challenging to decipher the respective roles of the HS chain and the core protein on proteoglycan functions. While the sulfation patterns of HS dictate many activities, the core protein can potentially impact HS functions. In order to decipher this, homogeneous proteoglycan glycopeptides are needed. Herein, we report the first successful synthesis of proteoglycan glycopeptides bearing multiple aspartic acids in the core peptide and O- and N-sulfations in the glycan chain, as exemplified by the syndecan-4 glycopeptides. To overcome the high acid sensitivities of sulfates and base sensitivities of the glycopeptide during synthesis, a new synthetic approach has been developed to produce a sulfated glycan chain on a peptide sequence prone to the formation of aspartimide side products. The availability of the structurally well-defined synthetic glycopeptide enabled the investigation of their biological functions including cytokine, growth factor binding and heparanase inhibition. Interestingly, the glycopeptide exhibited context dependent enhancement or decrease of biological activities compared to the peptide or the glycan alone. The results presented herein suggest that besides varying the sulfation patterns of HS, linking the HS chain to core proteins as in proteoglycans may be an additional approach to modulate biological functions of HS in nature.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Synthetic targets 1 and 2.
Fig. 2
Fig. 2. Obstacles encountered in HS glycopeptide synthesis. (a) The formation of aspartimide during peptide synthesis; (b) the formation of γ-hydroxy lactam during the conversion of homoserine to Asp; (c) the potential elimination of glycan chain under basic conditions.
Scheme 1
Scheme 1. Retrosynthetic design of HS glycopeptide 2.
Scheme 2
Scheme 2. Stereochemical outcomes of glycosylation of disaccharide 7 with various acceptors.
Fig. 3
Fig. 3. Proposed pathway for stereochemical outcome of disaccharide 7 glycosylation.
Scheme 3
Scheme 3. Synthesis of trisaccharide serine 11.
Scheme 4
Scheme 4. Synthesis of pentasaccharide – dipeptide module 15.
Scheme 5
Scheme 5. Failure in peptide elongation of glycopeptide 4.
Scheme 6
Scheme 6. Stability test of 6-O-DCV sulfate in model compound 18.
Scheme 7
Scheme 7. Synthesis of glycopeptide containing two DCV sulfate groups and full length core peptide.
Scheme 8
Scheme 8. Global deprotection and biotinylation to form glycopeptide 1.
Scheme 9
Scheme 9. Synthesis of (a) compound 30; and (b) compound 31.
Fig. 4
Fig. 4. Representative binding poses of glycopeptide 2 with site 1 of FGF2.
Fig. 5
Fig. 5. Comparison of (a) glycan 28 and (b) glycopeptide 2 in heparin binding site of heparanase.

Similar articles

Cited by

References

    1. Capila I. Linhardt R. J. Angew. Chem. Int. Ed. 2002;41:390–412. doi: 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B. - DOI - PubMed
    1. Powell A. K. Yates E. A. Fernig D. G. Turnbull J. E. Glycobiology. 2004;14:17R–30R. doi: 10.1093/glycob/cwh051. - DOI - PubMed
    1. Petitou M. van Boeckel C. A. A. Angew. Chem., Int. Ed. 2004;43:3118–3133. doi: 10.1002/anie.200300640. - DOI - PubMed
    1. Bernfield M. Götte M. Park P. W. Reizes O. Fitzgerald M. L. Lincecum J. Zako M. Annu. Rev. Biochem. 1999;68:729–777. doi: 10.1146/annurev.biochem.68.1.729. - DOI - PubMed
    1. Lindahl U. Kusche-Gullberg M. Kjellen L. J. Biol. Chem. 1998;273:24979–24982. doi: 10.1074/jbc.273.39.24979. - DOI - PubMed